Loading…
Academic Journal
Treatment of chronic heart failure with a very low dose of antibodies to C-fragment of type 1 angiotensin II receptor
T. M. Poponina, Ye. S. Noll, Yu. S. Poponina, B. F. Portnyagin, N. M. Simonova
Бюллетень сибирской медицины, Vol 8, Iss 4(2), Pp 86-91 (2009)
Saved in:
Title | Treatment of chronic heart failure with a very low dose of antibodies to C-fragment of type 1 angiotensin II receptor |
---|---|
Authors | T. M. Poponina, Ye. S. Noll, Yu. S. Poponina, B. F. Portnyagin, N. M. Simonova |
Publication Year |
2009
|
Source |
Бюллетень сибирской медицины, Vol 8, Iss 4(2), Pp 86-91 (2009)
|
Description |
The open randomized placebo-controlled prospective study was conducted; we documented improvement of global contractility and diastolic function of left ventricle, clinical and psychological status in 60 patients with chronic heart failure receiving a very low dose of antibodies to C-end fragment to AT1 receptors of angiotensin II for 6 months (Cardosten). The drug was well-tolerated.
|
Document Type |
article
|
Language |
English
Russian |
Publisher Information |
Siberian State Medical University (Tomsk), 2009.
|
Subject Terms | |